(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -18,500.00%-184M | -4.17%138M | -5.74%230M | -2.35%498M | -41.40%109M | -98.89%1M | 48.45%144M | 78.10%244M | 47.83%510M | 129.63%186M |
Net income from continuing operations | -100.00%-14M | -10.53%17M | 62.22%73M | 1,337.50%115M | 928.57%58M | 87.50%-7M | 35.71%19M | -21.05%45M | -69.23%8M | -135.00%-7M |
Operating gains losses | -800.00%-9M | 42.31%-15M | -26.67%-19M | -59.46%-59M | 15.00%-17M | -114.29%-1M | -2,500.00%-26M | 37.50%-15M | -311.11%-37M | -433.33%-20M |
Depreciation and amortization | 5.48%77M | 2.78%74M | 0.00%73M | -0.68%293M | 11.94%75M | -13.10%73M | 0.00%72M | 0.00%73M | -1.99%295M | -14.10%67M |
Asset impairment expenditure | ---- | ---- | ---- | -76.47%20M | ---- | ---- | ---- | ---- | --85M | ---- |
Deferred tax | 120.00%1M | -40.00%3M | 41.18%24M | 290.00%39M | 266.67%22M | 66.67%-5M | --5M | -10.53%17M | -44.44%10M | -57.14%6M |
Other non cashItems | 8.00%27M | -4.88%39M | -21.21%26M | -3.65%132M | -8.33%33M | -7.41%25M | 13.89%41M | -13.16%33M | -4.86%137M | 12.50%36M |
Change In working capital | -275.76%-248M | -27.94%49M | -29.13%73M | -53.64%51M | -212.50%-54M | -232.00%-66M | 518.18%68M | 10,200.00%103M | 711.11%110M | 237.14%48M |
-Change in receivables | ---- | ---- | ---- | 125.30%21M | ---- | ---- | ---- | ---- | -1,085.71%-83M | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | -81.44%36M | ---- | ---- | ---- | ---- | 3,980.00%194M | ---- |
-Change in other current assets | ---- | ---- | ---- | -500.00%-6M | ---- | ---- | ---- | ---- | 83.33%-1M | ---- |
Dividends received (cash flow from operating activities) | 10.00%11M | 77.78%16M | -46.15%7M | 117.65%37M | 400.00%5M | -16.67%10M | 125.00%9M | --13M | -15.00%17M | 0.00%1M |
Interest paid (cash flow from operating activities) | -30.43%-30M | -13.33%-34M | -22.73%-27M | -7.96%-122M | -38.24%-47M | -27.78%-23M | 16.67%-30M | 12.00%-22M | 8.13%-113M | 0.00%-34M |
Interest received (cash flow from operating activities) | --5M | --5M | --4M | 100.00%16M | --16M | --0 | --0 | --0 | --8M | ---- |
Tax refund paid | 20.00%-4M | -14.29%-16M | -33.33%-4M | -271.43%-26M | -300.00%-4M | -400.00%-5M | -366.67%-14M | -50.00%-3M | 50.00%-7M | 0.00%-1M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -18,500.00%-184M | -4.17%138M | -5.74%230M | -3.31%496M | -43.39%107M | -98.89%1M | 48.45%144M | 78.10%244M | 48.70%513M | 133.33%189M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -91.53%-113M | -178.13%-178M | 50.59%-42M | 60.82%-268M | 87.68%-60M | 1.67%-59M | 17.95%-64M | -44.07%-85M | -57.97%-684M | -711.67%-487M |
Net PPE purchase and sale | 14.52%-53M | -224.39%-133M | 47.37%-40M | -5.69%-260M | -8.00%-81M | -55.00%-62M | 47.44%-41M | -43.40%-76M | -47.31%-246M | 19.35%-75M |
Net intangibles purchas and sale | 64.71%-6M | -266.67%-11M | ---- | -150.00%-20M | 0.00%6M | -70.00%-17M | -50.00%-3M | ---- | 33.33%-8M | --6M |
Net business purchase and sale | -268.75%-54M | -280.00%-19M | -200.00%-9M | 105.38%22M | 99.50%-2M | 500.00%32M | ---5M | ---3M | -46.07%-409M | ---401M |
Net investment purchase and sale | ---- | ---- | ---- | 425.00%21M | ---- | ---- | ---- | ---- | --4M | ---- |
Net other investing changes | ---- | 0.00%-15M | 216.67%7M | -24.00%-31M | 80.95%-4M | -500.00%-12M | -850.00%-15M | 0.00%-6M | -196.15%-25M | -163.64%-21M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -91.53%-113M | -178.13%-178M | 50.59%-42M | 60.82%-268M | 87.68%-60M | 1.67%-59M | 17.95%-64M | -44.07%-85M | -57.97%-684M | -711.67%-487M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 88.24%-8M | 98.44%-1M | -143.66%-31M | -141.76%-109M | -400.00%-48M | 31.31%-68M | -116.33%-64M | 247.92%71M | 248.00%261M | 214.29%16M |
Net issuance payments of debt | 161.90%26M | 178.79%52M | -120.29%-14M | 89.27%-41M | -106.45%-2M | 16.00%-42M | 80.30%-66M | 346.43%69M | -334.36%-382M | 158.33%31M |
Net common stock issuance | ---- | ---25M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash dividends paid | 0.00%-17M | 0.00%-17M | 0.00%-17M | 0.00%-68M | 0.00%-17M | 0.00%-17M | 0.00%-17M | 0.00%-17M | 0.00%-68M | 0.00%-17M |
Net other financing activities | -88.89%-17M | -157.89%-11M | ---- | ---- | ---- | 71.88%-9M | -97.45%19M | 733.33%19M | 3,655.00%711M | 122.22%2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 88.24%-8M | 98.44%-1M | -143.66%-31M | -141.76%-109M | -400.00%-48M | 31.31%-68M | -116.33%-64M | 247.92%71M | 248.00%261M | 214.29%16M |
Net cash flow | ||||||||||
Beginning cash position | -1.52%585M | 7.73%627M | 35.24%472M | 36.33%349M | -25.60%468M | -15.26%594M | 102.08%582M | 36.33%349M | -6.91%256M | 153.63%629M |
Current changes in cash | -142.06%-305M | -356.25%-41M | -31.74%157M | 32.22%119M | 99.65%-1M | -82.61%-126M | -96.11%16M | 666.67%230M | 792.31%90M | -4,128.57%-282M |
Effect of exchange rate changes | --8M | 75.00%-1M | -166.67%-2M | 33.33%4M | 150.00%5M | --0 | -300.00%-4M | 50.00%3M | 150.00%3M | 100.00%2M |
End cash Position | -38.46%288M | -1.52%585M | 7.73%627M | 35.24%472M | 35.24%472M | -25.60%468M | -15.26%594M | 102.08%582M | 36.33%349M | 36.33%349M |
Free cash from | -211.54%-243M | -106.00%-6M | 13.10%190M | -16.60%216M | -73.33%32M | -295.00%-78M | 488.24%100M | 100.00%168M | 56.02%259M | 1,100.00%120M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data